New diabetes drug ZT002 passes first safety check in healthy volunteers
NCT ID NCT05491421
First seen Jan 18, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This early-stage study tested a new drug called ZT002 in 32 healthy adults to see if it is safe and how the body processes it. The goal is to develop a treatment for type 2 diabetes. Participants received either the drug or a placebo, and researchers monitored for side effects. This is a first step before testing in people with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Q-Pharm Pty Limited
Herston, Queensland, Australia
Conditions
Explore the condition pages connected to this study.